Literature DB >> 2825721

Inhibition of mast cell adenosine responsiveness by chronic exposure to adenosine receptor agonists.

D L Marquardt1, L L Walker.   

Abstract

Mast cell adenosine receptors are up-regulated functionally and numerically by chronic exposure to receptor antagonists, but their response to long-term treatment with receptor agonists has not been studied. To address this issue cultured mouse bone marrow-derived mast cells were exposed to N-ethylcarboxamide adenosine (NECA), an adenosine receptor agonist that augments stimulated mast cell mediator release. Cells grown for 3 days in 1 nM NECA responded normally to A23187 or antigen in releasing beta-hexosaminidase, but the ability of exogenous adenosine to potentiate this mediator release was attenuated markedly. This inhibition of adenosine responsiveness was partially present after 10 min of 1 microM NECA exposure and complete after 4 hr. The inhibitory effects could be reversed by washing NECA-exposed cells and returning them to culture for more than 4 hr. The adenosine present in the fetal calf serum coupled with deoxycoformycin attenuated mast cell adenosine responsiveness. The NECA-treated cells also exhibited a hyporesponsiveness to adenosine's augmentation of cell cyclic AMP content. This hyporesponsiveness was specific for adenosine receptors in that exogenous isoproterenol was able to increase cyclic AMP levels to a similar degree in both control and NECA-treated cells. Thus, chronic NECA exposure induces a homologous desensitization of mast cell adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825721     DOI: 10.1016/0006-2952(87)90674-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  8 in total

Review 1.  Mast cells. Receptors, secretagogues, and signaling.

Authors:  Bhavya B Sharma; John R Apgar; Fu-Tong Liu
Journal:  Clin Rev Allergy Immunol       Date:  2002-04       Impact factor: 8.667

2.  Mast cells retain their responsiveness upon continuous and repetitive exposure to antigen.

Authors:  M Shalit; D Pickholz; F Levi-Shaffer
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

3.  Calcium mobilization in activated mast cells monitored by flow cytometric analysis.

Authors:  G L Rossi; D J Young; S I Wasserman; K E Barrett
Journal:  Agents Actions       Date:  1990-11

4.  The effect of calcium removal on the suppression by adenosine of epileptiform activity in the hippocampus: demonstration of desensitization.

Authors:  H Hosseinzadeh; T W Stone
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

5.  Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation.

Authors:  Joris G De Man; Tom C Seerden; Benedicte Y De Winter; Eric A Van Marck; Arnold G Herman; Paul A Pelckmans
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

6.  Adenosine-induced bronchoconstriction of isolated lung and trachea from sensitized guinea-pigs.

Authors:  J R Thorne; K J Broadley
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

7.  Mast cell desensitization to IgE fails to induce a parallel adenosine receptor desensitization.

Authors:  D L Marquardt; A Lwin; L L Walker
Journal:  Agents Actions       Date:  1993-09

8.  Inhibition of protein kinase A fails to alter mast cell adenosine responsiveness.

Authors:  D L Marquardt; L L Walker
Journal:  Agents Actions       Date:  1994-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.